The MIC is determined by preparing a dilution series of the chemical, adding agar or broth, then inoculating with bacteria or fungi, and incubating at a suitable temperature. The value obtained is largely dependent on the susceptibility of the microorganism and the antimicrobial potency of the chemical, but other variables can affect results too.[5] The MIC is often expressed in micrograms per milliliter (μg/mL) or milligrams per liter (mg/L).
The first step in drug discovery is often measurement of the MICs of biological extracts, isolatedcompounds or large chemical libraries against bacteria and fungi of interest.[9][10] MIC values provide a quantitative measure of an extract or compound's antimicrobial potency. The lower the MIC, the more potent the antimicrobial.[4] When in vitro toxicity data is available, MICs can also be used to calculate selectivity index values, a measure of off-target to target toxicity.[4]
^ abPfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D (December 2010). "Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods". Drug Resistance Updates. 13 (6): 180–195. doi:10.1016/j.drup.2010.09.002. PMID21050800.
^Bennani FE, Doudach L, El Rhayam Y, Karrouchi K, Cherrah Y, Tarib A, Ansar M, Faouzi ME (November 2022). "Identification of the new progress on pyrazole derivatives molecules as antimicrobial and antifungal agents". West African Journal of Medicine. 39 (11): 1217–1244. PMID36455285.
^McKinnon PS, Davis SL (April 2004). "Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases". European Journal of Clinical Microbiology & Infectious Diseases. 23 (4): 271–88. doi:10.1007/s10096-004-1107-7. PMID15015030. S2CID28455936.
^Turnidge JD, Ferraro MJ, Jorgensen JH (2003). "Susceptibility Test Methods: General Considerations". In Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds.). Manual of Clinical Microbiology (8th ed.). Washington: American Society of Clinical Microbiology. p. 1103. ISBN1-55581-255-4.
^O'Neill AJ, Chopra I (August 2004). "Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques". Expert Opinion on Investigational Drugs. 13 (8): 1045–63. doi:10.1517/13543784.13.8.1045. PMID15268641. S2CID24016698.